MAPT and dementia: Previous investigations have revealed that 3-MA can downregulate the expression of α-synuclein, amyloid precursor protein (APP), and phosphorylated Tau in the intestinal tissue of Parkinson’s disease dementia (PDD) mice, potentially alleviating PDD symptoms through the brain–gut axis pathway [32].